Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03292471 · ClinicalTrials.gov registry record · NA

Effects of rTMS on Brain Activation in Aphasia

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
16
Enrollment target

NCT03292471: Completed NA study, sponsored by VA Office of Research and Development.

NCT03292471 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03292471, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target

Study Summary

This study will investigate the use of repetitive transcranial magnetic stimulation (rTMS), a non-invasive brain stimulation method, to improve word-finding abilities in Veterans and non-Veterans with chronic language problems following stroke (aphasia). Improving word-finding is important because word-finding difficulties are among the most common and debilitating consequences of aphasia. Although rTMS has shown promise as a treatment approach, not all individuals with aphasia show the same level of benefit. Specifically, this study will use functional magnetic resonance imaging (fMRI) to examine whether the likelihood of improved word-finding abilities following rTMS depends on pre-intervention language-related brain activity and will examine changes in brain activity in response to stimulation. A better understanding of how and for whom rTMS works will 1) help to identify the best candidates for rTMS treatment, 2) optimize rTMS treatment protocols to improve patient outcomes, and 3) improve the investigators' understanding of how the brain re-organizes language functions following stroke.

Interventions

  • DEVICE Transcranial Magnetic Stimulation

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2018-01-01
Est. Completion 2019-12-31
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT03292471

The ClinicalTrials.gov registry entry for NCT03292471 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Transcranial Magnetic Stimulation is the first listed.

NCT03292471 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03292471 about?

NCT03292471 is a clinical study titled "Effects of rTMS on Brain Activation in Aphasia". This study will investigate the use of repetitive transcranial magnetic stimulation (rTMS), a non-invasive brain stimulation method, to improve word-finding abilities in Veterans and non-Veterans with chronic language problems following stroke (aphasia). Improving word-finding is important because w...

What is the current status of trial NCT03292471?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2018-01-01. Estimated completion is 2019-12-31.

What interventions are being tested in trial NCT03292471?

The interventions under investigation include: Transcranial Magnetic Stimulation (DEVICE).

Who is sponsoring clinical trial NCT03292471?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.